Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Vascular Surgery|September 25, 2010
Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shuntJohn D Regan, Kathleen D Gibson, Janet E Rush, et al.Seminars in Vascular Surgery|August 6, 2010
What is the current role of foam sclerotherapy in treating reflux and varicosities?David D I WrightPerspectives in Vascular Surgery and Endovascular Therapy|July 16, 2009
The ESCHAR trial: should it change practice?David D I WrightThe Patient|March 27, 2016
Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) InstrumentDavid D I Wright, Jean Paty, Diane M Turner-Bowker, et al.American Heart Journal|June 1, 2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromesRichard C Becker, Frederick A Spencer, Michael Gibson, et al.Journal of Materials Science. Materials in Medicine|October 10, 2015
The role of clinically-relevant parameters on the cohesiveness of sclerosing foams in a biomimetic vein modelDario Carugo, Dyan N Ankrett, Vincent O'Byrne, et al.Pharmacotherapy|October 18, 2013
Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapyBrigitte C Widemann, Stefan Schwartz, Nalini Jayaprakash, et al.Journal of Materials Science. Materials in Medicine|March 21, 2013
A novel biomimetic analysis system for quantitative characterisation of sclerosing foams used for the treatment of varicose veinsDario Carugo, Dyan N Ankrett, Vincent O'Byrne, et al.Phlebology|June 4, 2015
Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foamsDario Carugo, Dyan N Ankrett, Xuefeng Zhao, et al.Pageof 1